PL3035965T4
Bi-specific monovalent diabodies that are capable of binding cd123 and cd3, and uses therof
Abstract
This record has no abstract on file.
Term
7.9 yearsto projected expiry
Projected expiry 20 August 2034, counted from filing; an application has no term until it is granted.
- Priority
- Filed
- Published
- Today
- Projected expiry
60 members in 38 offices
Priority claims5
| Document | Office | Kind | Date |
|---|---|---|---|
| 201361869510 | United States of America | P | |
| 201361907749 | United States of America | P | |
| 13198784 | European Patent Office (EPO) | A | |
| 201461990475 | United States of America | P | |
| 2014051790 | United States of America | W |
Members60
| Document | Office | Kind | |
|---|---|---|---|
| EP2839842A1 | European Patent Office (EPO) | A1 | |
| CA2920116A1 | Canada | A1 | |
| WO2015026892A1 | World Intellectual Property Organization (WIPO) | A1 | |
| TW201542593A | Taiwan Province of China | A | |
| AP2016009029A0 | African Regional Intellectual Property Organization (ARIPO) | A0 | |
| AR097405A1 | Argentina | A1 | |
| AU2014308905A1 | Australia | A1 | |
| SG11201601317UA | Singapore | A | |
| IL244237A0 | Israel | A0 | |
| IL244237D0 | Israel | D0 | |
| KR20160045134A | Republic of Korea | A | |
| PH12016500311A1 | Philippines | A1 | |
| PH12016500311B1 | Philippines | B1 | |
| PE20160509A1 | Peru | A1 | |
| MX2016002260A | Mexico | A | |
| EP3035965A1 | European Patent Office (EPO) | A1 | |
| CR20160108A | Costa Rica | A | |
| US2016200827A1 | United States of America | A1 | |
| CN105873607A | China | A | |
| EA201690443A1 | Eurasian Patent Organization (EAPO) | A1 | |
| CL2016000362A1 | Chile | A1 | |
| JP2017504577A | Japan | A | |
| EP3035965A4 | European Patent Office (EPO) | A4 | |
| TN2016000046A1 | Tunisia | A1 | |
| ZA201600653B | South Africa | B | |
| HK1225999A | Hong Kong, China | A | |
| HK1225999A1 | Hong Kong, China | A1 | |
| US9822181B2 | United States of America | B2 | |
| BR112016003417A2 | Brazil | A2 | |
| US2018094072A1 | United States of America | A1 | |
| AU2014308905B2 | Australia | B2 | |
| JP6524087B2 | Japan | B2 | |
| UA119539C2 | Ukraine | C2 | |
| TWI669310B | Taiwan Province of China | B | |
| GEP20197053B | Georgia | B | |
| EA034142B1 | Eurasian Patent Organization (EAPO) | B1 | |
| CN105873607B | China | B | |
| MX373374B | Mexico | B | |
| IL244237A | Israel | A | |
| IL244237B | Israel | B | |
| US10787521B2 | United States of America | B2 | |
| EP3035965B1 | European Patent Office (EPO) | B1 | |
| DK3035965T3 | Denmark | T3 | |
| US2021047426A1 | United States of America | A1 | |
| PT3035965T | Portugal | T | |
| RS61522B1 | Serbia | B1 | |
| LT3035965T | Lithuania | T | |
| HRP20210215T1 | Croatia | T1 | |
| EP3808776A1 | European Patent Office (EPO) | A1 | |
| SMT202100123T1 | San Marino | T1 | |
| PL3035965T3 | Poland | T3 | |
| PL3035965T4This record | Poland | T4 | |
| SI3035965T1 | Slovenia | T1 | |
| KR102287523B1 | Republic of Korea | B1 | |
| HUE054315T2 | Hungary | T2 | |
| SA516370567B1 | Saudi Arabia | B1 | |
| SA8650B1 | Saudi Arabia | B1 | |
| NZ716914A | New Zealand | A | |
| ES2860973T3 | Spain | T3 | |
| CY1123940T1 | Cyprus | T1 |
Numbers
- Publication
- 3035965
- Application
- 14837858
Titles2
- English
- BI-SPECIFIC MONOVALENT DIABODIES THAT ARE CAPABLE OF BINDING CD123 AND CD3, AND USES THEROF
- Polish
- Dwuswoiste jednowartościowe diaciała zdolne do wiązania CD123 i CD3 oraz ich zastosowania
Classification
- CPC, 21
- C07K16/2809
- C07K16/2896
- A61P11/06
- A61K2039/505
- C07K16/2866
- C07K2317/31
- C07K2317/33
- C07K2317/56
- C07K2317/626
- C07K2317/73
- C07K2317/92
- C07K2319/30
- C07K2319/31
- A61P17/02
- A61P19/02
- A61P29/00
- A61P35/00
- A61P35/02
- A61P35/04
- A61P37/00
- A61P37/08
- IPC, 11
- A61P11 06
- A61K39 00
- A61P17 02
- A61P19 02
- A61P29 00
- A61P35 00
- A61P35 02
- A61P35 04
- A61P37 00
- A61P37 08
- C07K16 28